John Hall is an investment analyst in the U.S. Equity Division, working with the health care team on the analysis of drug pipelines and existing therapeutic agents. John is a vice president of T. Rowe Price Group, Inc. He is also a vice president and an Investment Advisory Committee member of the Heath Sciences and Small-Cap Stock Funds.
Years at T.Rowe Price
Years investment experience
Invest With Confidence®
We’re driven by our purpose: To identify and actively invest in opportunities to help people thrive in an evolving world.
Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier.